IDT Australia Ltd (IDT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH59177D
- Pages: 32
- December 2018
- Total Views:1193
- Region : Asia
- GlobalData
- Equity Research Report
Details
Summary
IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes in the post-discovery pharmaceutical life cycle. It manages Cytotoxic API's, high potency API's, anti-cancer drugs, antibiotics, anti-psychotics, beta lactams and controlled drugs. IDT provides a wide range of services, which can be customized to meet the specific requirements of its customer. The company also provides specialist clinical trial labeling, packaging and dispensing services. IDT is headquartered in Boronia, Victoria, Australia.
IDT Australia Ltd (IDT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Partnerships 12
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
Equity Offering 14
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For USD 2.8 Million 15
IDT Australia Completes Private Placement Of Shares For USD 0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For USD 1.8 Million 17
Asset Transactions 18
ANI Pharma Acquires Generic ANDA Product Portfolio from IDT Australia for USD2.7 Million 18
I'rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 19
Acquisition 21
I'rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 21
I'rom Completes Acquisition Of 18.8% Stake In IDT Australia For USD 2 Million 22
IDT Australia Ltd-Key Competitors 23
IDT Australia Ltd-Key Employees 24
IDT Australia Ltd-Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
Aug 23, 2018: IDT Australia: Preliminary final report for the year ended 30 June 2018 26
Corporate Communications 27
Jul 02, 2018: IDT Australia Appoints Chief Executive Officer 27
Feb 16, 2018: IDT Australia Names Dr David Sparling As Interim Chief Executive Officer 28
Jun 13, 2017: IDT Australia: Dr Graeme Blackman AO retires 29
Legal and Regulatory 30
Jul 25, 2018: IDT Australia: FDA Meeting Update 30
Other Significant Developments 31
Jun 08, 2018: IDT Australia: Update on Response to Fda Warning Letter 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List Of Figure
List of Figures
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
IDT Australia Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IDT Australia Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For USD 2.8 Million 15
IDT Australia Completes Private Placement Of Shares For USD 0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For USD 1.8 Million 17
ANI Pharma Acquires Generic ANDA Product Portfolio from IDT Australia for USD2.7 Million 18
I'rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 19
I'rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 21
I'rom Completes Acquisition Of 18.8% Stake In IDT Australia For USD 2 Million 22
IDT Australia Ltd, Key Competitors 23
IDT Australia Ltd, Key Employees 24
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
IDT Australia Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes in the post-discovery pharmaceutical life cycle. It manages Cytotoxic API's, high potency API's, anti-cancer drugs, antibiotics, anti-psychotics, beta lactams and controlled drugs. IDT provides a wide range of services, which can be customized to meet the specific requirements of its customer. The company also provides specialist clinical trial labeling, packaging and dispensing services. IDT is headquartered in Boronia, Victoria, Australia.
IDT Australia Ltd (IDT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Partnerships 12
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
Equity Offering 14
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For USD 2.8 Million 15
IDT Australia Completes Private Placement Of Shares For USD 0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For USD 1.8 Million 17
Asset Transactions 18
ANI Pharma Acquires Generic ANDA Product Portfolio from IDT Australia for USD2.7 Million 18
I'rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 19
Acquisition 21
I'rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 21
I'rom Completes Acquisition Of 18.8% Stake In IDT Australia For USD 2 Million 22
IDT Australia Ltd-Key Competitors 23
IDT Australia Ltd-Key Employees 24
IDT Australia Ltd-Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
Aug 23, 2018: IDT Australia: Preliminary final report for the year ended 30 June 2018 26
Corporate Communications 27
Jul 02, 2018: IDT Australia Appoints Chief Executive Officer 27
Feb 16, 2018: IDT Australia Names Dr David Sparling As Interim Chief Executive Officer 28
Jun 13, 2017: IDT Australia: Dr Graeme Blackman AO retires 29
Legal and Regulatory 30
Jul 25, 2018: IDT Australia: FDA Meeting Update 30
Other Significant Developments 31
Jun 08, 2018: IDT Australia: Update on Response to Fda Warning Letter 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List Of Figure
List of Figures
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
IDT Australia Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IDT Australia Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For USD 2.8 Million 15
IDT Australia Completes Private Placement Of Shares For USD 0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For USD 1.8 Million 17
ANI Pharma Acquires Generic ANDA Product Portfolio from IDT Australia for USD2.7 Million 18
I'rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 19
I'rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 21
I'rom Completes Acquisition Of 18.8% Stake In IDT Australia For USD 2 Million 22
IDT Australia Ltd, Key Competitors 23
IDT Australia Ltd, Key Employees 24
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
IDT Australia Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020